Literature DB >> 20177338

Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy.

Rachel J Johnson1, Susan V Fuggle, John O'Neill, Samantha Start, J Andrew Bradley, John L R Forsythe, Chris J Rudge.   

Abstract

BACKGROUND: Outcomes after deceased heart beating donor kidney transplantation are good, but survival rates vary according to a number of donor-, recipient-, and transplant-related factors. This comprehensive analysis of transplant outcomes was undertaken to inform development of a new Kidney Allocation Scheme.
METHODS: A complete case analysis of the outcome of kidney-only transplants in the United Kingdom, 1995 to 2001, was undertaken using Cox regression modeling. Seven thousand three hundred eighty-five (77%) of the 9585 transplants reported to the UK Transplant Registry were primary transplants in adults. Regrafts and pediatric patients (age <18 years) were analyzed separately. Transplant and patient survival over 5 years were investigated in addition to causes of prolonged cold ischemia time (CIT).
RESULTS: A variety of factors significantly adversely influenced kidney transplant and patient outcome, including older donor age, older recipient age, waiting time to transplant over 2 years, diabetes, and earlier year of transplant. Human leukocyte antigen mismatch and CIT were significant in analyses of transplant but not in patient outcome, and an increased graft failure rate was also identified in adolescent patients. CIT was prolonged by long-distance kidney exchanges between centers (2 hr) and reallocation of kidneys for alternative patients (7 hr).
CONCLUSION: This study identified a number of factors that influence transplant outcome after deceased heart beating donor kidney transplant in the United Kingdom. The findings suggest that the influences of human leukocyte antigen mismatch and CIT are most relevant in considering a revised kidney allocation scheme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177338     DOI: 10.1097/TP.0b013e3181c90287

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

2.  Compatibility and kidney transplantation: the way to go.

Authors:  Ilias I N Doxiadis
Journal:  Front Immunol       Date:  2012-05-14       Impact factor: 7.561

3.  An important measure taken for China Organ Transplant Response System.

Authors:  Hongtao Zhao; Haibo Wang; Miao Pu; Jie Zhao; You Wu; Ying Shi; Jiefu Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

4.  Geographic Variation in Cold Ischemia Time: Kidney vs. Liver Transplantation in the United States, 2003-2011.

Authors:  Naoru Koizumi; Debasree DasGupta; Amit V Patel; Tony E Smith; Jeremy D Mayer; Clive Callender; Joseph K Melancon
Journal:  Transplant Direct       Date:  2015-08-13

5.  The impact of human leukocyte antigen mismatching on graft survival and mortality in adult renal transplantation: A protocol for a systematic review and meta-analysis.

Authors:  Xinmiao Shi; Wenke Han; Jie Ding
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients.

Authors:  Xinmiao Shi; Jicheng Lv; Wenke Han; Xuhui Zhong; Xinfang Xie; Baige Su; Jie Ding
Journal:  BMC Nephrol       Date:  2018-05-18       Impact factor: 2.388

7.  Predicting patient survival after deceased donor kidney transplantation using flexible parametric modelling.

Authors:  Bernadette Li; John A Cairns; Matthew L Robb; Rachel J Johnson; Christopher J E Watson; John L Forsythe; Gabriel C Oniscu; Rommel Ravanan; Christopher Dudley; Paul Roderick; Wendy Metcalfe; Charles R Tomson; J Andrew Bradley
Journal:  BMC Nephrol       Date:  2016-05-25       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.